Strong Q1 FY27: consolidated revenue up 164%, PAT up 93% YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin CompressionResults View source PDF

FCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.2%1-day move

₹41.85

prior close

₹43.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.5-5.5-5.9-8.2-3.2-3.0————————

Up moveDown movePending

AI summary

Fineotex Chemical's Q1 FY27 consolidated results show strong growth. Total income rose to Rs. 38,672 lakhs from Rs. 14,622 lakhs YoY (up 164.48%). Operational EBITDA climbed to Rs. 5,914 lakhs from Rs. 2,520 lakhs (up about 135%). PAT grew to Rs. 4,821 lakhs from Rs. 2,503 lakhs (up 92.61%). Volume grew 131% YoY and ROIC stood at 33%. Standalone revenue declined to Rs. 8,515 lakhs from Rs. 9,826 lakhs though PAT edged up. Board recommended a final dividend of Rs. 0.05 per share for FY26. Auditors gave an unqualified limited review report.

Likely market impact

Strong consolidated growth, mainly from subsidiaries, should boost sentiment. However, EBITDA and PAT margins compressed, and standalone business remains weak.